Gene · 406950
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of neoplasm-specific signatures of miRNA interactions by employing a systems biology approach. | PeerJ | 2022 | 36213495 | PubTator, text mining | PubMed |
| MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy. | Front Pharmacol | 2022 | 36210816 | PubTator, text mining | PubMed |
| Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16. | Life Sci Alliance | 2022 | 36202613 | PubTator, text mining | PubMed |
| Study of the role of microRNAs 16 and 135a in patients with lifelong premature ejaculation receiving fluoxetine daily for 3 months: A prospective case control study. | Andrologia | 2022 | 36177782 | PubTator, text mining | PubMed |
| A message passing framework with multiple data integration for miRNA-disease association prediction. | Sci Rep | 2022 | 36171337 | PubTator, text mining | PubMed |
| Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine. | Genes Dis | 2022 | 36157483 | PubTator, text mining | PubMed |
| MiRNA as a Potential Target for Multiple Myeloma Therapy-Current Knowledge and Perspectives. | J Pers Med | 2022 | 36143213 | PubTator, text mining | PubMed |
| Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications. | Int J Mol Sci | 2022 | 36142536 | PubTator, text mining | PubMed |
| miRNA in Molecular Diagnostics. | Bioengineering (Basel) | 2022 | 36135005 | PubTator, text mining | PubMed |
| Expression pattern of non-coding RNAs in non-functioning pituitary adenoma. | Front Oncol | 2022 | 36119500 | PubTator, text mining | PubMed |
| Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients. | Eur Rev Med Pharmacol Sci | 2022 | 36111932 | PubTator, text mining | PubMed |
| The prognostic value of MicroRNAs associated with fatty acid metabolism in head and neck squamous cell carcinoma. | Front Genet | 2022 | 36110217 | PubTator, text mining | PubMed |
| Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction. | Transl Oncol | 2022 | 36103755 | PubTator, text mining | PubMed |
| MiRNA-16-1 Suppresses Mcl-1 and Bcl-2 and Sensitizes Chronic Lymphocytic Leukemia Cells to BH3 Mimetic ABT-199. | Cell J | 2022 | 36093807 | PubTator, text mining | PubMed |
| A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors. | Explor Target Antitumor Ther | 2022 | 36071980 | PubTator, text mining | PubMed |
| Dynamic Protein-RNA recognition in primary MicroRNA processing. | Curr Opin Struct Biol | 2022 | 36067707 | PubTator, text mining | PubMed |
| Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. | Cell Mol Biol Lett | 2022 | 36064322 | PubTator, text mining | PubMed |
| microRNA expression in acute myeloid leukaemia: New targets for therapy? | EJHaem | 2022 | 36051053 | PubTator, text mining | PubMed |
| Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. | J Clin Lab Anal | 2022 | 36036748 | PubTator, text mining | PubMed |
| MicroRNA-16 Represses TGF-β1-induced Epithelial-to-Mesenchymal Transition in Human Lung Adenocarcinoma Cell Line. | Microrna | 2022 | 36029069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406950/papers?page=8